Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior ...
Moderna noted the FDA did not identify any specific safety concerns with the vaccine and that the rejection was inconsistent ...
An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. This study, led by ...
Immunization is one of the most effective health interventions we can make. Every year vaccination programmes save millions of lives. They have helped eradicate diseases like smallpox – a deadly virus ...
HHS Spokesman Andrew Nixon told The National News Desk via email that the FDA rejected Moderna’s application for filing ...
The post Clinical Trials Show Moderna's New mRNA Flu Vaccine Is Safe and Effective. FDA Won't Even Consider It. appeared ...
The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...
Viral vectors and vaccines navigate public distrust while advancing through AI design, COVID response lessons, and promising ...
From early failures to prefusion F protein breakthroughs, RSV vaccine development has accelerated, reshaping prevention ...
Paul Griffin is a director and scientific advisory board member of the immunisation coalition. He has served on Medical Advisory Boards including for AstraZeneca, GSK, MSD, Moderna, Biocelect/Novavax, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results